Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, Gareth J. Morgan, Paul G. Richardson et al.|Leukemia|2011Cited by 721
Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-xL is an essential survival protein of human myeloma cellsSophie Derenne, Martine Amiot, Brett P. Monia et al.|Blood|2002Cited by 430